卢皮醇对颗粒物介导的肺炎的有益作用
Sanghee Cho1, Dong Ho Park2, Eui Kyun Park3
1College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, 41566, South Korea.
概括
烯醇是一种植物化合物,可以防止细颗粒物 (PM2.5) 引起的肺损伤. 它减少了炎症,并改变了PM2.5毒性的关键分子通路.
科学领域:
- 环境健康 环境健康
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 暴露于颗粒物 (PM2.5) 是一个主要的环境健康问题,与严重的肺损伤有关.
- 在药用植物中发现的植物化学物质如lupeol,显示出治疗应用的希望,包括抗癌性质.
研究的目的:
- 调查卢皮醇对PM2.5暴露引起的肺损伤的保护作用.
- 阐明卢皮醇潜在治疗作用背后的分子机制.
主要方法:
- 鼠被暴露在PM2.5的内内,随后用lupeol进行治疗.
- 评估了肺损伤,湿/干重比,血管透性,炎症标志物和特定的分子通路 (TLR4,MyD88,mTOR,自).
主要成果:
- 烯醇治疗显著降低了PM2.5诱导的肺损伤和血管透性.
- 卢佩醇降低了炎症性细胞因子,BALF中的总蛋白质和淋巴细胞增殖.
- 卢皮醇调节了TLR4,MyD88,LC3 II,贝克林1和mTOR酸化的表达.
结论:
- 露皮醇显示出对PM2.5诱导的肺损伤有显著的保护作用.
- 卢皮醇的治疗潜力可能涉及TLR4-MyD88和mTOR-自信号通路的调节.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Drugs Used in Lower Respiratory Disorders: Overview
386
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
386


